Table 2 Patients’ characteristics
Alive without recurrence N = 211 | Death from non-cancer related cause N = 33 | P value | |
|---|---|---|---|
Age | 77 (70–95) | 80 (71–89) | 0.015 |
Gender | 0.41 | ||
Male | 145 (68.7%) | 25 (75.8%) | |
Female | 66 (31.3%) | 8 (24.2%) | |
BMI | 22.8 (15.3 – 33.3) | 20.9 (14.7—34.2) | < 0.001 |
Charlson Comorbidity Index | 0.003 | ||
Low | 96 (45.5%) | 6 (18.2%) | |
Medium | 90 (42.7%) | 17 (51.5%) | |
High | 24 (11.4%) | 8 (24.2%) | |
Very high | 1 (0%) | 2 (6.1%) | |
ASA-PS | 0.29 | ||
1 | 10 (5.0%) | 0 (0%) | |
2 | 150 (74.6%) | 25 (75.8%) | |
3 | 39 (19.4%) | 8 (24.2%) | |
4 | 2 (1.0% | 0 (0%) | |
Modified GPS | 0.37 | ||
0 | 158 (74.9%) | 21 (63.6%) | |
1 | 36 (17.1%) | 9 (27.3%) | |
2 | 17 (8.1%) | 3 (9.1%) | |
PNI | 48.1 (24.5 – 64.2) | 45.6 (29.7 – 56.6) | 0.051 |
NLR | 2.37 (0.76 – 16.14) | 2.55 (1.11 – 16.0) | 0.08 |
Surgical approach | 0.23 | ||
Open surgery | 85 (40.3%) | 17 (51.5%) | |
Minimal invasive surgery | 126 (59.7%) | 16 (48.5%) | |
Surgical procedure | 0.84 | ||
TG | 48 (22.8%) | 7 (21.2%) | |
Non-TG (DG / PG) | 163 (77.3%) | 26 (78.8%) | |
Overall surgical complications | 0.021 | ||
Presence | 59 (27.8%) | 16 (48.5%) | |
Absence | 152 (72.0%) | 17 (51.5%) | |
Histological classification | 0.27 | ||
Undifferentiated | 71 (33.7%) | 8 (24.2%) | |
Differentiated | 140 (66.4%) | 25 (75.8%) | |
Pathological T status | 0.75 | ||
T2-4 | 96 (45.5%) | 16 (48.5%) | |
T1 | 115 (54.5%) | 17 (51.5%) | |
Pathological N status | 0.12 | ||
N1-3 | 58 (28.6%) | 14 (42.4%) | |
N0 | 145 (71.4%) | 19 (57.6%) | |
Pathological Stage | 0.54 | ||
I | 128 (61.1%) | 16 (48.5%) | |
II | 56 (26.5%) | 11 (33.3%) | |
III | 26 (12.3%) | 6 (18.2%) | |
Adjuvant chemotherapy | 0.42 | ||
Presence | 37 (17.5%) | 4 (12.1%) | |
Absence | 174 (82.5%) | 29 (87.9%) |